362 related articles for article (PubMed ID: 32816910)
21. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A
Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600
[TBL] [Abstract][Full Text] [Related]
22. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
[TBL] [Abstract][Full Text] [Related]
23. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.
Nielsen GP; Stemmer-Rachamimov AO; Ino Y; Moller MB; Rosenberg AE; Louis DN
Am J Pathol; 1999 Dec; 155(6):1879-84. PubMed ID: 10595918
[TBL] [Abstract][Full Text] [Related]
24. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
Brossier NM; Carroll SL
Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
[TBL] [Abstract][Full Text] [Related]
25. Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.
Mitchell DK; Burgess B; White EE; Smith AE; Sierra Potchanant EA; Mang H; Hickey BE; Lu Q; Qian S; Bessler W; Li X; Jiang L; Brewster K; Temm C; Horvai A; Albright EA; Fishel ML; Pratilas CA; Angus SP; Clapp DW; Rhodes SD
Clin Cancer Res; 2024 Mar; 30(5):1038-1053. PubMed ID: 38127282
[TBL] [Abstract][Full Text] [Related]
26. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.
Jessen WJ; Miller SJ; Jousma E; Wu J; Rizvi TA; Brundage ME; Eaves D; Widemann B; Kim MO; Dombi E; Sabo J; Hardiman Dudley A; Niwa-Kawakita M; Page GP; Giovannini M; Aronow BJ; Cripe TP; Ratner N
J Clin Invest; 2013 Jan; 123(1):340-7. PubMed ID: 23221341
[TBL] [Abstract][Full Text] [Related]
27. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
28. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations.
Carroll SL; Stonecypher MS
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1115-23. PubMed ID: 15581179
[TBL] [Abstract][Full Text] [Related]
30. Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.
Hirbe AC; Dahiya S; Miller CA; Li T; Fulton RS; Zhang X; McDonald S; DeSchryver K; Duncavage EJ; Walrath J; Reilly KM; Abel HJ; Pekmezci M; Perry A; Ley TJ; Gutmann DH
Clin Cancer Res; 2015 Sep; 21(18):4201-11. PubMed ID: 25925892
[TBL] [Abstract][Full Text] [Related]
31. Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma.
Naber U; Friedrich RE; Glatzel M; Mautner VF; Hagel C
J Neurooncol; 2011 Jun; 103(2):239-45. PubMed ID: 20821344
[TBL] [Abstract][Full Text] [Related]
32. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
33. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.
Woodruff JM
Am J Med Genet; 1999 Mar; 89(1):23-30. PubMed ID: 10469433
[TBL] [Abstract][Full Text] [Related]
34. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
35. PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.
Keng VW; Rahrmann EP; Watson AL; Tschida BR; Moertel CL; Jessen WJ; Rizvi TA; Collins MH; Ratner N; Largaespada DA
Cancer Res; 2012 Jul; 72(13):3405-13. PubMed ID: 22700876
[TBL] [Abstract][Full Text] [Related]
36. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
[TBL] [Abstract][Full Text] [Related]
37. Other Nerve Sheath Tumors of Brain and Spinal Cord.
Petrov M; Sakelarova T; Gerganov V
Adv Exp Med Biol; 2023; 1405():363-376. PubMed ID: 37452945
[TBL] [Abstract][Full Text] [Related]
38. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling.
Carroll SL; Stonecypher MS
J Neuropathol Exp Neurol; 2005 Jan; 64(1):1-9. PubMed ID: 15715079
[TBL] [Abstract][Full Text] [Related]
40. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
